APN News

Akums Drugs collaborates with LC Ingredients for exclusive rights to make & market Cynatine in India

Delhi :  Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing   pharmaceutical   company in India, has   recently   forged a prestigious and Exclusive collaboration with LC Ingredients to procure the raw material, manufacture, innovate & sell finished products containing Cynatine to all Indian big pharma and nutraceutical companies for the benefit of consumers. This move is another affirmation of Akums’ commitment to innovation and customer centric approach, since they identified a gap in the supplements market and bridged it as promptly as possible.

Deficiency of the fibrous protein called keratin in hair and nails results in increase in hair loss, thin and grey hair, as well as easily breakable and discolored fingernails. Conversely, lack of keratin in the skin makes it more prone to wrinkles, sagging, and dullness. Keratin, in its original form, is insoluble and non-absorbable by the body, hence cannot be consumed by humans. However, Cynatine’s high bioavailability makes it capable of delivering keratin peptides to the body and can be consumed by humans, with no fear of toxicity associated with it. This is a revolutionary step-up in the healthcare and supplements segment, and Akums will write the Indian chapter of Cynatine’s story.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain says, “In the erstwhile market, there were no healthcare supplements other than Biotin and regular hair, nail and skin (HNS) multivitamins for controlling hair fall and other related issues, but necessarily 100 percent effective. We identified this gap and when we found out about Cynatine, the only soluble source of keratin known, we connected with the innovator company LC ingredients with the aim to get exclusive rights so that we may introduce this revolutionary healthcare supplement in India. This collaborative effort will bridge the current availability gap for keratin soluble supplements. We are happy to announce that we will be the first and sole sellers of Cynatine in the Indian market.  At Akums, we are glad to have yet added another ‘first’ to our laurels.”

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain says, “Even though Cynatine is a soluble form of Keratin, it has not yet been listed with the regulatory authority FSSAI; means that no pharmaceutical company in India is permitted to produce it. This makes Akums, the only company in India with exclusive rights to sell this supplement. We have already conducted our own clinical trials on the Indian population and classified the supplement within the normal foods category. Cynatine reduces hair loss, boosts hair strength, and enhances hair’s radiance and shine. It helps to promote firmness and elasticity in skin, minimizes fine lines and wrinkles, and improves strength by binding to the nail. And we are extremely excited to market it so that the Indian consumers may benefit from using it too.”

About   Akums-   Akums   Drugs   &   Pharmaceuticals   Ltd.   is   the   largest   contract   manufacturing pharmaceutical   company   of   India, manufacturing   more   than 12% of India’s consumption.  The organization deals in the manufacturing and export of formulations in a wide spectrum of dosage forms   &   therapeutic   segments.   The   company   is   currently   supplying   to   almost   all   Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer of the country. The 10 state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactam and non-beta lactam formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, Ayurvedic, food supplements & nutraceuticals and animal health care.

In a span of few years, the organization has become the icon of Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements.

With a crème-de-la-crème of dedicated pharmaceutical personnel and standardized practices, Akums has been successful in attaining national and international accreditations, and building trust on the basis of efficacy, safety & quality. The organization is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi amongst others and exports to 53 countries across the world.

Exit mobile version